Jun.

Investment of 3.15% stake in vivozon, a non-narcotic analgesic development company

Oct.

Obtained whole sale business license.

Jun.

Export of Neuromed injections to China.

Jan.

Release of AtoIB, a specialized cosmetic product for atopic dermatitis.

Oct.

Acquisition of OTC pharmaceuticals manufacturing business.

Oct.

Designation as an advanced industry for pharmaceutical manufacturing.

Aug.

Expansion and remodeling of raw material warehouse.

Jul.

Acquisition of food distribution and sales business.

May

Establishment of a new factory site within the Osong Life Science Complex.

Dec.

Expansion and remodeling of finished product storage facilities.

Nov.

Awarded the production technology contribution award by the Korean Pharmaceutical Association.

Oct.

Introduction of child safety packaging for oral solid dosage products.

Oct.

Release of 'kinerase', series through technology partnership with 'Valeant' in the U.S.

Dec.

Commendation by the mayor of Icheon for contributions to local economic revitalization.

Jan.

Implementation of ERP - Enterprise Resource Planning system for comprehensive resource management.

Jul.

Acquisition of specialized health functional food manufacturing business.

Oct.

Second remodeling of pharmaceutical manufacturing business.

Oct.

Introduction of EU-GMP standard, initiation of validation process.

Aug.

Release of Seractil through technology partnership with Gebro in Austria.

Dec.

Registration of Patent No. 31790 (Claroma)

Dec.

Initiation of raw material synthesis.

Dec.

Commencement of export to Yemen and Malaysia.

May

Release of comprehensive cold medicine "HABEN PLUS', the first in Korea to use plant based HPMC capsules.

Dec.

Listing on KOSDADQ

Dec.

Selection of excellent companies in pharmaceutical analysis and quality control management business.

Dec.

Listing on KOSDADQ

Sept.

First remodeling of pharmaceutical manufacturing facility.

Apr.

Automation of ointment manufacturing facility.